‍We are developing several Alive partnerships and are simultaneously seeking new topic areas and partners. Please get in touch to find out how you can get involved.

Yes, if helpful, Alive can help identify partners and broker relationships between organisations. Alive has extensive networks in various policy domains and geographies and is well-placed to help find partners to join current and forthcoming partnerships.

‍Alive can act as a facilitator and broker to help build a partnership. We can also provide guides and templates for partnerships that can be adapted to your specific needs. We have methodological expertise in living evidence and can advise and support living evidence generation. We also have an online partnership platform that can provide a space for a partnership-specific data repository and share other partnership resources. To find out more, please contact us.

‍We suggest that partnerships last for 2 years initially, with the possibility to extend the duration. The length of the partnership will be largely determined by the demands and priorities of the evidence users within it. Partnerships may engage additional partners over time and/or expand to encompass additional topics and question areas.

‍No, Alive is developing partnerships across a broad range of domains, including health, education, climate action and social disadvantage. The most important driver of topic selection is tangible demand from advisory and decision-making organizations.

‍As we develop partnerships, we are simultaneously developing our pricing model. This is to ensure that evidence arising from our partnerships is trustworthy, timely and affordable. To find out more about partnership opportunities and to discuss costs, please contact us.

‍Yes. We are committed to equity of access to evidence and are developing a pricing model that includes subsidized costs for those in poorly resourced settings.

‍We are committed to open science and to disseminating the evidence that emerges from partnerships to the widest possible audience. We are experimenting with different funding models to enable this. Some partnerships are making all outputs available free and open and some partnerships explore forms of cost-sharing, such as when there is no external funding available.

‍Cochrane’s Editor-in-Chief, Karla Soares-Weiser, and Tamara Kredo from Cochrane South Africa are on the Alive Council, and we are currently working to establish Cochrane-led partnerships.

Campbell Collaboration CEO, Will Moy, is on the Alive Council, and we are currently working to establish Campbell-led partnerships.

Alive is not a legal entity; it is a collaborative initiative. Secretariat support is provided by the Future Evidence Foundation, a global nonprofit organization registered in Australia with a mission to change how the world creates and uses trustworthy knowledge.

Alive is currently testing different financial models for scale and sustainability. As a non-profit initiative all funds are used to support the evidence partnerships. A small amount of funding (from external sources or partnerships, depending on the financial model being tested) is used by the Future Evidence Foundation to support partnership convening and secretariat support for the Alliance.

No. Covidence is a systematic review software platform developed by a separate group within the Future Evidence Foundation. Alive does not have a relationship with Covidence and all Alive partnerships make their own decisions about what software to use.

No. Alive partnerships make their own decisions about what software they use.